Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

The problem was resolved Thursday, when lawmakers sent a $240 million supplemental budget to Governor Maura Healey, which she ...

Four states joined a federal lawsuit against CVS Pharmacy that claims the company caused state Medicaid programs to pay ...

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Rite Aid to sell 1,000 pharmacy assets to CVS ... failed to address its long-term business challenges. Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge Eli Lilly on Thursday ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

After Donald Trump signed an executive order slashing drug prices last week, experts have highlighted how PBMs could be hit the hardest despite pharmaceutical companies facing the potential of ...

Lilly Star Weight-Loss Drug Zepbound Faces Coverage Challenge From CVS Health Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...